🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What happens if we apply Lancet Commission’s “clinical obesity” definition to the population? 👉A downgrading of the obesity epidemic pubmed.ncbi.nlm.nih.gov/40197716/ First study to examine prevalence of #obesity in the Middle Eastern according to typical BMI cutoffs vs ethnic specific

Webinar recording now available on Sarcopenic Obesity This COMs webinar provides an overview of the EASO/ @ESPEN_org Guidelines for Diagnosis of Sarcopenic Obesity + knowledge on sarcopenic obesity development across life stages easo.org/video/sarcopen… #Obesity

Cool new infographic from EASO about the health impacts of obesity. easo.org/new-infographi…

jamanetwork.com/journals/jama/…

The rising prevalence of people with a high #BMI, increasing rates of type 2 #diabetes, and a greater fall risk in people with #obesity and type 2 diabetes has contributed to a substantial rise in #fractures thelancet.com/journals/landi… #T2D #osteoporosis #BoneHealth

Good news 📰! nejm.org/doi/full/10.10…

Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period? ccjm.org/content/92/4/2…

There is no clear consensus regarding the optimal approach to screening patients prior to initiating the medications and/or evaluating for thyroid cancer during GLP-1 RA treatment. academic.oup.com/jcem/advance-a…

AbArginase, mantiene los efectos de la pérdida de peso al suspender la medicación, estudios en 🐁 #ECO2025 ObesitySEEN

arGLP1 after bariatric surgery was associated with lower MACE #ECO2025

elespanol.com/ciencia/salud/… “El efecto inesperado de los AR-GLP1 reducen el riesgo de Cáncer Relacionados con la Obesidad” vía EL ESPAÑOL SEEDO

No te puedes perder la I Reunion del Area de Obesidad de la Seen que tendra lugar el próximo 13 de junio en Madrid. Te esperamos! Sociedad SEEN

New American Diabetes Association - DiabetesPro Consensus Statement released today: MASLD is now recognized as a major complication in type 2 diabetes and obesity, with clear metabolic origins tied to insulin resistance and cardiometabolic risk factors. Early identification and intervention are essential

💊Nueva píldora formativa Sociedad SEEN ObesitySEEN seen.es/pildoras-video…

📢 New study in >4M patients with T2DM Do GLP-1 receptor agonists increase thyroid tumor risk? ❌ No. Compared to SGLT2is, DPP-4is, and SUs, no increased risk of thyroid tumors or malignancy was found. 🔍 Large multinational study with robust methods (PSM, ITT & on-treatment

2025 ACC Scientific Statement on the Management of Obesity in Adults With #Heartfailure : A Report of the American College of Cardiology JACC Journals 📋 jacc.org/doi/10.1016/j.…

In the SURPASS-3 MRI substudy, tirzepatide was associated with potentially favourable changes in muscle fat infiltration and reductions in muscle volume broadly in accordance with the general association between changes in muscle volume and bodyweight. thelancet.com/journals/landi…

La Guía GIRO para el manejo de la #obesidad tiene múltiples ramificaciones, y el "fatty kidney" es una de ellas. SEEDO Sociedad SEEN S.E.N. Nefrología Mar Malagon Andreea Ciudin Maria Jose Soler Endocrinologia i Nutrició Vall d'Hebron Vall d'Hebron Institut de Recerca Vall d'Hebron Sociedad Española de Medicina Interna (SEMI) SEMERGEN | Médicos de AP #YoPrefieroMFyC SED Diabetes #SomosMuchos